fashion -WSS

fashion

author：fashion 2025-10-01 00:17:28 - browse：89793

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Grail is spending more than ever lobbying Congress

WSS

Connecting traumatic brain injury and domestic violence

Did the public have the right to know Arthur Ashe had AIDS?

Pfizer's Covid pill remains 89% effective in final analysis, company says

Artificial intelligence use in health care faces greater scrutiny in 2024

Ebola vaccine can save some who are already sick, per new study

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Wikipedia

fashion

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Listen: Biogen's messy board & Laronde's data problem

BioMarin wins approval for gene therapy to treat hemophilia A

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Trump demands the U.S. pay no more for drugs than other countries … again

Websites selling Wegovy, Zepbound ingredients targeted by FDA

How one medical school became remarkably diverse

Congress must protect the remaining independent doctors

How one medical school became remarkably diverse

7 people shot in DC, police say

leisure time

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Can food be medicine? And other questions about a new push

When is a doctor not a doctor? Try when patients address women doctors

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

focus

hotspot

focus